Seeking Alpha

Jefferies still bullish on Opko despite short call

  • Jefferies is out with some commentary on Opko Health (OPK +5.2%) amid controversy surrounding a short thesis advanced by Lakewood Capital (see Lakewood's article on SA here).
  • "In our view, timely achievements of its laid-out milestones and future sales revenues meeting our expectations (albeit significantly lower than its noted market opportunities) would likely provide potential upside to current levels," analyst Eun Yang says.
  • Buy rating reiterated.
  • Price target is $11.50.
Comments (4)
  • Qniform
    , contributor
    Comments (2456) | Send Message
    What an annoying site at that embedded link for commentary. I hate those mouse cursor pop-ups...
    18 Dec 2013, 12:23 PM Reply Like
  • phredwelll
    , contributor
    Comments (6) | Send Message
    I think opko shares are being bought by chairman Frost for family rather than for himself. Opko will be at $36.00 by mid 2014.
    18 Dec 2013, 12:44 PM Reply Like
  • Kf919hk
    , contributor
    Comment (1) | Send Message
    What make you the stock would go that high?
    9 Feb, 12:31 PM Reply Like
  • Spuzdude
    , contributor
    Comments (3) | Send Message
    Agree. The Doctor is way ahead of these short sellers.
    18 Dec 2013, 03:34 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: